Page last updated: 2024-09-04

rhodioloside and sb 202190

rhodioloside has been researched along with sb 202190 in 1 studies

Compound Research Comparison

Studies
(rhodioloside)
Trials
(rhodioloside)
Recent Studies (post-2010)
(rhodioloside)
Studies
(sb 202190)
Trials
(sb 202190)
Recent Studies (post-2010) (sb 202190)
62125196510202

Protein Interaction Comparison

ProteinTaxonomyrhodioloside (IC50)sb 202190 (IC50)
Mitogen-activated protein kinase 13Homo sapiens (human)0.08
Bromodomain-containing protein 4Homo sapiens (human)2.95
TyrosinaseMus musculus (house mouse)0.03
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)0.08
Casein kinase I isoform deltaHomo sapiens (human)0.188
Mitogen-activated protein kinase 12Homo sapiens (human)0.08
Mitogen-activated protein kinase 11Homo sapiens (human)0.1038
Mitogen-activated protein kinase 14Homo sapiens (human)0.0625
Tau-tubulin kinase 2Homo sapiens (human)9.34
large T antigenBetapolyomavirus macacae4.87

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, J; Zhang, YL; Zhuang, N1

Other Studies

1 other study(ies) available for rhodioloside and sb 202190

ArticleYear
[Salidroside inhibits inflammatory factor release in BV-2 cells through p38 and JNK pathways].
    Sheng li xue bao : [Acta physiologica Sinica], 2018, Jun-25, Volume: 70, Issue:3

    Topics: Animals; Anthracenes; Apoptosis; Cell Survival; Cells, Cultured; Glucosides; Imidazoles; Inflammation; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Microglia; p38 Mitogen-Activated Protein Kinases; Phenols; Phosphorylation; Pyridines; Tumor Necrosis Factor-alpha

2018